88
Participants
Start Date
September 30, 2006
Primary Completion Date
January 31, 2009
Study Completion Date
July 31, 2009
CYCLOPHOSPHAMIDE
50 mg x 2 /day , per os, nonstop until disease progression or toxicity or patient decision
MEGESTROL
320 mg/day, per os, 2 pills of 160 mg one time, nonstop until disease progression or toxicity or patient decision
Centre Oscar Lambret, Lille
Hopital Saint Vincent, Lille
Centre Hospitalier Regional - Dermatology, Lille
Centre Hospitalier Regional - Oncology, Lille
Centre Oscar Lambret
OTHER